Fulcrum Therapeutics, Inc.FULCNASDAQ
Loading
Year-over-year gross profit growth rate
Latest
0.00%
↓ 100% vs avg
Percentile
P39
Within normal range
Streak
1 qtr
Consecutive declineDecelerating
Average
334.55%
Historical baseline
| Period | Value |
|---|---|
| Q4 2025 | 0.00% |
| Q3 2025 | 100.00% |
| Q2 2025 | 0.00% |
| Q1 2025 | 100.00% |
| Q4 2024 | 0.00% |
| Q3 2024 | -100.00% |
| Q2 2024 | 13197.91% |
| Q1 2024 | -231.96% |
| Q4 2023 | 102.08% |
| Q3 2023 | -3.01% |
| Q2 2023 | -3.34% |
| Q1 2023 | 8.17% |
| Q4 2022 | -26.07% |
| Q3 2022 | 38.70% |
| Q2 2022 | -51.83% |
| Q1 2022 | -10.00% |
| Q4 2021 | -14.10% |
| Q3 2021 | 6.58% |
| Q2 2021 | -12.58% |
| Q1 2021 | 3.15% |
| Q4 2020 | 13.57% |
| Q3 2020 | -28.00% |
| Q2 2020 | 21.53% |
| Q1 2020 | -2545.86% |
| Q4 2019 | 96.15% |
| Q3 2019 | -24.27% |
| Q2 2019 | 68.64% |
| Q1 2019 | 0.00% |
| Q4 2018 | 0.00% |
| Q3 2018 | 0.00% |
| Q2 2018 | 0.00% |
| Q1 2018 | 0.00% |